Inflammatory Myofibroblastic Tumor of the Small Bowel Mesentery: An Unusual Cause of Abdominal Pain and Uveitis

Choi, Audrey H.; Bohn, Olga L.; Beddow, Timothy D.; McHenry, Christopher R.

doi:10.1007/s11605-010-1408-3

Cited by 21 publications

(15 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Recurrences are more common during the first year in IMT-ALK positive tumors. Metastases are rare (5%) and predominate in TMI-ALK negative tumors (9).…”

Section: Discussionmentioning

confidence: 99%

Hemoperitoneum secondary to perforated inflammatory myofibroblastic tumor: A case report of an unusual complication

Cholvi-Calduch¹,

Fernández-Moreno²,

Díaz-Tobarra³

et al. 2015

Rev Esp Enferm Dig

View full text Add to dashboard Cite

“…Recurrences are more common during the first year in IMT-ALK positive tumors. Metastases are rare (5%) and predominate in TMI-ALK negative tumors (9).…”

Section: Discussionmentioning

confidence: 99%

Hemoperitoneum secondary to perforated inflammatory myofibroblastic tumor: A case report of an unusual complication

Cholvi-Calduch¹,

Fernández-Moreno²,

Díaz-Tobarra³

et al. 2015

Rev Esp Enferm Dig

View full text Add to dashboard Cite

“…Most IMTs occur in the lungs and airways of young patients. However, other organs, including mesentery, omentum, stomach, small intestine, large intestine, mediastinum, retroperitoneum, liver and bladder, have been documented (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11). Among these extrapulmonary IMTs, 43% arise in the mesentery and omentum (29).…”

Section: Discussionmentioning

confidence: 99%

“…IMT used to be considered as an inflammatory pseudotumor, xanthogranuloma, plasma-cell granuloma, plasma-cell pseudotumor or an inflammatory myofibroblastic tumor. IMT commonly occurs in the lung, mesentery, omentum and retroperitoneum, but it may also be observed in the extremities, head and neck region, liver, spleen, thyroid, gastrointestinal tract, genitourinary tract and other systems (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11). The tumors usually follow a benign course, but recurrences have been documented in up to 25% of cases.…”

Section: Introductionmentioning

confidence: 99%

Primary inflammatory myofibroblastic tumor of the breast with rapid recurrence and metastasis: A case report

Zhao¹,

Wang

et al. 2012

Oncology Letters

View full text Add to dashboard Cite

Abstract. Primary inflammatory myofibroblastic tumor (IMT) of the breast is extremely rare; only 19 cases have been reported in the English literature. In the present study, we present a case of IMT in a 56-year-old female patient who was admitted to our hospital due to a mass found in her right breast. Mammogram and ultrasound revealed a well-circumscribed mass and surgery was performed. Histopathologically, the lesion was composed of spindle and inflammatory cells, including plasma cells and lymphocytes. Mitotic figures were not observed. Immunohistochemically, the tumor cells were positive for SM-actin, anaplastic lymphoma kinase (ALK) and vimentin and focal positive for desmin, but negative for NSE, S-100, CD117, CD34, NF, CD21, CD35 and CD68. Thus, we made a diagnosis of IMT and advised regular follow-up. However, the patient had local recurrence and metastasis to the left groin area 3, 7 and 10 months after the initial surgery. Notably, the histopathological characteristics of the recurrent and metastatic foci were similar to those of the initial specimen, but mitotic figures were clearly observed. Thus, we conclude that IMT shows occasionally malignant biological behavior although it is a neoplasm of intermediate biological potential that frequently recurs and rarely metastasizes. We advise that clinical physicians should regularly follow up patients after focal resection for IMT.

show abstract

“…В одном случае наряду с абдоминальным синдромом была описана клиническая картина увеита [40]. ВМО может быть причиной инвагинационной тонкокишечной непроходимости [41,42].…”

Section: вмо тонкой кишкиunclassified

Inflammatory tumors of the digestive tract

Maskin¹,

Karsanov²

2014

Onkol. Z. im. P.A. Gercena

View full text Add to dashboard Cite

2, 31 volgograd State Medical university; 2 north-ossetian State Medical Academy; 3 passenger terminal hospital at the vladikavkaz Station, oAo «rzhD», vladikavkaz рассмотрены вопросы этиологии, морфологической и иммуногистохимической характеристики, клинических проявле-ний, диагностики, лечения воспалительных миофибробластических опухолей органов пищеварительного тракта. приве-дены данные о причинах рецидивов и консервативных методах лечения. показано, что основная трудность лечения за-ключается в выборе адекватного объема резекции и непредсказуемом течении послеоперационного периода, а в качестве перспективного направления для прогноза исхода лечения предполагается поиск достоверных критериев дифференциа-ции между агрессивными и неагрессивными формами воспалительных опухолей. Ключевые слова: воспалительные миофибробластические опухоли, пищеварительный тракт, диагностика, лечение.the paper considers the etiology, morphological and immunohistochemical characteristics, clinical manifestations, diagnosis, and treatment of inflammatory miofibroblastic tumors of the digestive tract. it gives data on causes of relapses and conservative treatments. it is shown that the main difficulty in their treatment is due to the choice of an adequate resection volume and to an unpredictable postoperative period; and a search for significant criteria for differentiation between the aggressive and non-aggressive forms of inflammatory tumors is assumed to be as a promising area to predict the outcome of their treatment.

show abstract

Inflammatory Myofibroblastic Tumor of the Small Bowel Mesentery: An Unusual Cause of Abdominal Pain and Uveitis

Abstract: IMT should be considered in the differential diagnosis for a mesenteric mass.

Cited by 21 publications

References 37 publications

Hemoperitoneum secondary to perforated inflammatory myofibroblastic tumor: A case report of an unusual complication

Hemoperitoneum secondary to perforated inflammatory myofibroblastic tumor: A case report of an unusual complication

Primary inflammatory myofibroblastic tumor of the breast with rapid recurrence and metastasis: A case report

Inflammatory tumors of the digestive tract

Contact Info

Product

Resources

About